Search Within

Sergio Andres Giralt

  1. "Farid Boulad"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (13)
Groups
  1. Bone Marrow Transplant (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. Hematologic Malignancies, Division of (35)
  5. Pediatrics, Department of (35)
  6. Stem Cell Transplantation and Cellular Therapy Service (35)

More Groups

People
  1. Farid Boulad (35)
  2. Esperanza Papadopoulos (34)
  3. Ann Jakubowski (31)
  4. Richard O'Reilly (31)
  5. Miguel-Angel Perales (30)
  6. Nancy Kernan (29)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2020 (6)
  4. 2017 (2)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (15)
  2. Blood (12)
  3. Blood Advances (2)
  4. Journal of Clinical Investigation (2)
  5. Leukemia and Lymphoma (2)
  6. Bone Marrow Transplantation (1)

More Publications

Publishers
  1. Elsevier Inc. (15)
  2. American Society of Hematology (14)
  3. American Society for Clinical Investigation (2)
  4. Taylor & Francis Group (2)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Adenovirus viral kinetics and mortality in ex vivo T cell-depleted hematopoietic cell transplant recipients with adenovirus infection from a single center
    Journal Article

    Lee, Y. J.; Fang, J.; Zavras, P. D.; Prockop, S. E.; Boulad, F.; Tamari, R.; Perales, M. A.; Papadopoulos, E. B.; Jakubowski, A. A.; Giralt, S. A.; more...
    Journal of Infectious Diseases (2020)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • T cell depletion as an alternative approach for patients 55 years or older undergoing allogeneic stem cell transplantation as curative therapy for hematologic malignancies
    Journal Article

    Jakubowski, A. A.; Petrlik, E.; Maloy, M.; Hilden, P.; Papadopoulos, E.; Young, J. W.; Boulad, F.; Castro-Malaspina, H.; Tamari, R.; Dahi, P. B.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save